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Introduction 
Improvement of the dissolution rates of water-insoluble 
drugs  is  one  of  the  most  challenging  issues  of  drug 
development, because the enhanced dissolution rates can 
enhance drug oral bioavailability. 
1 The solid dispersion 
technique for water-insoluble drugs developed by Chiou 
and Reigelman
2 supplies an effective way to increase the 
dissolution rates of drugs. 
3,4 Details of different types of 
solid  dispersion  systems  and  the  mechanisms  of  drug 
release  from  these  systems  have  been  reviewed  in 
details.
2 Solid dispersion can be prepared by formulating 
supersaturated  systems  of  the  drug  employing  various 
types of carriers, ranging widely from water-soluble to 
amphiphilic and lipid-soluble ones.
4–7 Drugs molecularly 
dispersed  in  proper  carriers  may  reach  the  maximum 
levels  of  particle  size  reduction,  therefore  the  surface 
area  increase,  which  results  in  enhanced  dissolution 
rates.
8 
Numerous attempts 
9-16 have been made to improve the 
dissolution  rate  of  prednisolone,  a  very  slightly  water 
soluble glucocorticoid to obtain more rapid and complete 
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Introduction:  Prednisolone  is  a  class  II  substance  according  to  the  Biopharmaceutics 
Classification System. It is a poorly water soluble agent. The aim of the present study was 
to  improve  dissolution  rate  of  a  poorly  water-soluble  drug,  prednisolone,  by  a  solid 
dispersion technique. Methods: Solid dispersion of prednisolone was prepared with PEG 
6000 or different carbohydrates such as lactose and dextrin with various ratios of the drug 
to  carrier  i.e.,  1:10,  1:20  and  1:40.  Solid  dispersions  were  prepared  by  coevaporation 
method.  The  evaluation  of  the  properties  of  the  dispersions  was  performed  using 
dissolution  studies,  Fourier-transform  infrared  spectroscopy  and  x-ray  powder 
diffractometery. Results: The results indicated that lactose is suitable carriers to enhance 
the in vitro dissolution rate of prednisolone. The data from the x-ray diffraction showed 
that the drug  was still detectable in its solid state in all solid dispersions except solid 
dispersions prepared by dextrin as carrier. The results from infrared spectroscopy showed 
no well-defined drug–carrier interactions for coevaporates. Conclusion: Solid dispersion 
of a poorly water-soluble drug, prednisolone may alleviate the problems of delayed and 
inconsistent rate of dissolution of the drug. 
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absorption.  One  of  the  limitations  of  common  solvent 
method  is  the  need  for  a  solvent  that  dissolves 
hydrophilic  carrier  and  hydrophobic  drug  at  the  same 
time which may not be applicable for some carriers such 
as carbohydrates. In our previous investigations we have 
demonstrated  that  co-evaporates  with  hydrophilic 
carriers  could  be  prepared  by  using  two  different  but 
mutually soluble solvents.
17,18 Therefore the need for a 
common solvent of drug and carrier is not considered as 
an  absolute  requisite  for  preparation  of  co-evaporates. 
This  broadens  the  application  of  the  co-evaporation 
technique for more extensive range of drugs and carriers.  
In the present study, efforts were made to improve the 
dissolution  behavior  and  consequently  absorption,  of 
prednisolone by applying the solid dispersion technique 
using  lactose,  dextrin,  and  PEG  6000  as  hydrophilic 
carriers. 
Materials and methods 
Materials 
For  preparation  of  solid  dispersions  the  following 
materials  were  used:  lactose  monohydrate  (DMV, 
Netherland);  mannitol,  dextrin,  PEG  2000,  PEG 4000, 
PEG 6000 (Merck, Germany); prednisolone (Abureihan, 
Iran);  Chemicals  used  for  buffer  preparation  were 
reagent grade. All other materials used were of analytical 
or  high  performance  liquid  chromatography  (HPLC) 
grade and were purchased from Merck (Germany). 
Preparation of solid dispersions, physical mixtures and 
treated physical mixtures 
Physical mixtures were prepared by mixing prednisolone 
with the hydrophilic carriers for 5 min in 100 mL bottles, 
until a homogenous mixture was obtained. The resulting 
mixture was sieved and the 105–250 micron particle size 
fraction was obtained using 60-140 mesh screens. The 
powders  were  stored  in  a  screw-cap  vial  at  room 
temperature. 
Treated  physical  mixtures  were  prepared  by  mixing 
treated  drug  and  treated  carriers  in  100-mL  bottles. 
Treated drug was prepared by mixing alcoholic solution 
of prednisolone with distilled water until a homogenous 
mixture was obtained. Treated carrier was prepared by 
dissolving  it  in  water  and  adding  alcohol  96%  until  a 
homogenous mixture was obtained.  
The objective of preparation of treated physical mixtures 
is to investigate if evaporation of the drug and carrier 
separately  may  affect  release  of  the  drug  from  solid 
dispersions.  
Coevaporates  were  prepared  in  the  following 
prednisolone-carrier ratios: 1:10, 1:20, and 1:40 (w/w). 
Coevaporates  were  prepared  by  dissolving  the 
components separately in a minimum volume of ethanol 
or distilled water, respectively. The alcoholic solution of 
prednisolone was then poured into the aqueous solution 
of the carrier under continuous stirring. The mixture was 
then heated in a water bath (70°C) under vacuum and 
vigorous stirring.  
Initially, a transparent to a translucent viscous mass was 
observed  and  finally  a  pale  yellow  coevaporate  was 
formed.  The  moist  mass  was  transferred  to  a  vacuum 
desicator  and  kept  at  50oC  overnight.  The  solid  mass 
was  ground  and  the  particle  size  fraction  of  105–250 
micron  was  separated  using  60-140  mesh  screens  and 
kept in a screw-capped glass vial until use. 
 
Dissolution studies 
Hand–filled, hard gelatin capsules of the formulations, 
containing  5  mg  of  the  drug,  were  used  for  the 
dissolution studies. The test was conducted using USP 
30  Apparatus  I  at  50  rpm.  The  dissolution  medium 
consisted  of  900  ml  distilled  water  which  was 
maintained at 37 (±0.5) °C. The duration of the test was 
30  minutes.  A  5-ml  aliquots  were  withdrawn  at 
appropriate time intervals, and replaced with a 5 ml of 
distilled water and assayed by UV spectrophotometry at 
246.8 nm. Cumulative percentages of the drug dissolved 
from the preparations were calculated. Three replicates 
of each dissolution test were carried out. 
Mean  percent  dissolution  (MPD)  and  dissolution 
efficiency  (DE)
19,  were  used  to  compare  dissolution 
profiles of binary systems Eq. (1): 
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Wherei  is  the  sample  number,  n  is  the  number  of 
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Where Y is percent drug released as a function of time, T 
is the total time of drug release and Y100 is 100 percent 
drug released. 
Powder X-ray diffraction 
The  powder  X-ray  diffraction  (PXRD)  pattern  of  all 
ingredients and all binary systems were recorded using 
an  automated  siemens  X-ray  diffractometer  (Siemens 
D5000,  Munich,  Germany).  Cross  sections  of  the 
ingredients and all binary systems were taken and held in 
place on a quartz plate to Cu Kα radiation of wave length 
1.5406  A°.  The  samples  were  analyzed  at  room 
temperature  over  a  range  of  5-70°  2  with  sampling 
intervals of 0.02° 2 and scanning rate of 6°/min.  
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Fourier-transform infrared spectroscopy 
Fourier-transform  infrared  Spectroscopy  (FT-IR)  were 
obtained  on  a  Bomem  2000  FT-IR  system  (Bomem 
Quebec, Canada) using the KBr disk method. Samples 
were mixed with KBr powder and compressed to 10-mm 
discs by hydraulic press at pressure of 10 tons for 30 
seconds.  The  scanning  range  was  450-4000  cm
-1  and 
resolution was 2 cm
-1. 
Results and discussion 
Dissolution studies 
The  release  of  prednisolne  from  solid  dispersions, 
physical  mixtures  and  treated  physical  mixtures  was 
determined in distilled water. DE and MPD values are 
represented in Table 1. 
 
Table 1. DE and MPD of prednisolone-carrier binary systems (standard deviations were all less than 10%). 
Sample 
Pure 
drug 
Solid dispersion  Treated Physical 
mixture 
Physical mixture 
Drug Carrier Ratio  -  1:10  1:20  1:40  1:40  1:10  1:20  1:40 
Without carrier 
DE  20.65  -  -  -  -  -  -  - 
MPD  18.32  -  -  -  -  -  -  - 
Lactose  DE  -  80.98  83.18  80.71  71.24  65.39  73.73  70.24 
MPD  -  73.05  75.12  72.95  63.77  57.80  66.60  62.45 
Dextrin  DE  -  50.62  62.49  68.82  65.28  31.42  38.11  39.51 
MPD  -  45.10  56.00  61.31  58.37  27.47  33.68  34.41 
PEG 6000  DE  -  60.93  60.78  53.74  55.18  42.36  51.61  43.25 
MPD  -  53.95  52.90  46.05  48.42  35.76  44.14  37.17 
 
 
 
It  is  evident  that  the  dissolution  rate  of  the  solid 
dispersions  of  prednisolone  prepared  with  lactose, 
dextrin and PEG 6000, are higher than that of pure drug 
and  physical  mixtures  of  ingredients.  Moreover  the 
dissolution rate of treated physical mixtures was higher 
compared to related physical mixtures.  
Possible explanations of the increased dissolution rate of 
solid dispersions have been proposed by Craig and Ford 
20,21 , which include: reduction of drug crystallite size, a 
solubilization  effect  of  the  carrier,  absence  of 
aggregation  of  drug  crystallites,  improved  wettability 
and dispersibility of the drug, dissolution of the drug in 
the  hydrophilic  carrier,  conversion  of  the  drug  to  the 
amorphous  state  and  finally  the  combination  of  the 
above mentioned mechanisms. 
Dry mixing of prednisolone with carrier brings the drug 
in  close  contact  with  the  hydrophilic  carrier.  The 
increased dissolution rate observed in these cases can be 
contributed  to  several  factors  such  as  a  solubilization 
effect of the carrier, improved wettability of the drug and 
inhibition of particle aggregation.  
Dissolution  profiles  of  solid  dispersions  with  lactose 
showed  an  increase  in  the  dissolution  rate  of 
prednisolone  with  respect  to  the  drug  by  itself  which 
could be due to high hyrophilicity of lactose (Figure 1). 
Also, increasing the weight fraction of prednisolone in 
the  solid  dispersions  did  not  affect  noticeably  the 
dissolution  rate  of  the  dispersions  prepared  with 
lactose(Figure 2). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Dissolution profiles of physical mixtures (PM), treated 
physical  mixtures  (TPM)  and  solid  dispersions  (SD)  of 
prednisolone with lactose and Dextrin.  
   |    51  Advanced Pharmaceutical Bulletin, 2011, 1(1), 48-53  Copyright © 2011 by Tabriz University of Medical Sciences 
Zakeri-Milani et al. 
 
 
 
Figure  2.  FT-IR  spectra  of  pure  prednisolone,  lactose,  1:40  physical  mixture  (PM)  of  prednisolone  with  lactose,  and  1:40  solid 
dispersion (SD) of prednisolone with lactose 
 
 
This is not unexpected, as it has been previously shown 
that an increase in the weight fraction of the drug does 
not necessarily decrease the dissolution rate. 
17, 22Hence 
utilizing lactose in a ratio of 1:10 should be enough for 
reaching higher dissolution rate. 
As it can be seen from Figure 1, the solid dispersion of 
the  drug  with  dextrin  showed  enhanced  dissolution 
rate.
17, 18 
Compared  to  the  drug  alone,  an  improvement  in  the 
dissolution  rate  was  achieved  for  the  formulations 
containing  PEG  6000.  Dissolution  rate  was  decreased 
increasing the ratio of PEG 6000. This phenomenon may 
be attributed to formation of viscous boundary layer at 
the  surface  of  the  polymer  at  higher  carrier  ratios. 
However,  the  release  of  prednisolone  from  treated 
physical  mixtures  in  the  ratio  of  (1:40)  was  slightly 
faster than the release from coevaporates. This could be 
due  to  the  fact  that  dissolution  mechanism  of  solid 
dispersion  with  PEG  6000  might  be  predominantly 
diffusion-controlled, and presumably the high viscosity 
of  this  carrier  in  stagnate  layer  is  the  main  factor  to 
control the dissolution rate. 
 
Powder X-Ray Diffraction (PXRD) 
The extent of crystallinity  affects dissolution of  drugs. 
An  amorphous  or  metastable  form  will  dissolve 
promptly  because  of  its  higher  internal  energy  and 
greater  molecular  motion,  which  increase 
thermodynamic  properties  compared  to  crystalline 
materials.
23,24 Crystallinity was determined by comparing 
some representative peak heights in diffraction patterns 
of the solid dispersions with those of physical mixtures. 
Our  findings  revealed  that  prednisolone  was  in  its 
crystalline  forms  in  the  physical  mixtures  and  solid 
dispersions  prepared  with  lactose  without  any  change 
compared to the corresponding treated physical mixtures 
and physical mixtures of the drug. On the contrary solid 
dispersions prepared with dextrin were characterized by 
the  complete  absence  of  any  diffraction  peaks, 
suggesting a complete amorphization in the amorphous 
carrier.  In  the  case  of  solid  dispersions  prepared  with 
PEG  6000,  prednisolone  was  still  detectable  in 
crystalline  form.  Therefore  no  complete  amorphization 
occurred. 
 
Fourier-transform infrared spectroscopy 
Fourier-transform  infrared  (FT-IR)  spectroscopy  was 
used to further characterize possible interactions between 
the drug and carrier in the solid state. From the structures 
of the prednisolone, lactose, dextrin and PEG 6000, it 
can  be  assumed  that  possible  interaction  could  occur 
between thehydroxyl or carbonyl group of prednisolone 
and  the  hydroxyl  group  of  these  carriers.  Any  sign  of 
interaction  would  be  reflected  by  a  change  in  the 
position  of  C=O  vibration  and  disappearance  of  O-H 
stretching depending on the extent of interaction. 
The  results  from  FT-IR  spectroscopy  showed  that 
incorporation  of  prednisolone  into  PEG  6000,  lactose, 
did  not  modify  their  peak  positions  and  trends.  These 
results  further  indicate  the  absence  of  well-defined  
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interaction between prednisolone and PEG 6000, lactose 
as already confirmed from the X-ray diffraction study. 
The  spectrum  of  prednisolone  showed  characteristic 
bands of the OH group which were found at 3200-3500 
cm
-1 (OH involved in intermolecular association). Two 
carbonyl stretching peaks appears as a very strong band 
at  1708  cm
-1  and  1654  cm
-1.  The  spectrum  of  dextrin 
showed, amongst others, important bands at 2953 cm
-1 
(C–H  stretching)  and  1109  cm
-1  (C–O  stretching).  A 
very broad  band was  also visible  at 3446  cm
-1,  which 
was  attributed  to  the  presence  of  water.  Important 
vibrations detected in the spectrum of PEG 6000 are the 
C–H stretching at 2890 cm
-1 and the C–O stretching at 
1110 cm
-1 and OH stretching at 3350 cm
-1. Comparing 
the spectra of physical mixtures and solid dispersions of 
prednisolone  with  lactose,  PEG  6000,  and  dextrin  no 
difference was shown in the position of the absorption 
bands.  The  spectra  can  be  simply  regarded  as  the 
superposition  of  those  of  prednisolone  and  carrier. 
Although it could be expected to have hydrogen bonding 
between the hydrogen atom of the OH of the drug and 
one of the ione pairs of the oxygen atom in carrier, this 
could not be demonstrated. 
 
Conclusion 
An  increased  dissolution  rate  of  prednisolone  solid 
dispersions  was  observed  with  increasing  the  ratio  of 
dextrin to the drug. Controversially, the dissolution rate 
of the drug was not varied upon increasing the ratio of 
the carrier to the drug when the drug was dispersed in 
lactose. However decreased dissolution rate of the solid 
dispersions was achieved by increasing the ratio of PEG 
6000.  
In  conclusion  improving  the  dissolution  rate  of 
prednisolone solid dispersions using polysaccharides like 
lactose is more appropriate than using dextrin and PEG 
6000. 
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